The Board of Directors appointed Mrs. Priyanka Agarwal, member of ICSI (A36112) as the Company Secretary & Compliance Officer of the Company w.e.f 26th April 2025.
Change In Key Management
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 21 2025
- Resignation Of Ms. Pratibha Jhawar From The Post Of Company Secretary & Compliance Officer
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 09 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 28 2025
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended March 31St, 2025.
- Audited Financial Results March 31St 2025.
- Integrated Filing (Financial)
- Venmax Drugs & Pharmaceuticals Ltd. Press Release May 09 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals